BEBT-607 / BeBetter Med - LARVOL DELTA

Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation (clinicaltrials.gov) - P1 | N=126 | Recruiting | Sponsor: BeBetter Med Inc

Metastases • New P1 trial • Colorectal Cancer • Gastrointestinal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • KRAS • MSI • PD-L1